Ionis Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Ionis Pharmaceuticals, Inc. (IONS) reported Earnings Per Share, Basic and Diluted of $0.15 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2019-03-01
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2017-06-30 was -$0.02.
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2016-06-30 was -$0.47.
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2016-03-31 was -$0.52.
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2015-09-30 was -$0.30.
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2017 was $0.15.
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2016 was -$0.50.
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2015 was -$0.74.
- Ionis Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2014 was -$0.33.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.15 10-K · filed 2019-03-01 | ||||||
| 2017-06-30 | -$0.02 10-Q · filed 2018-08-07 | -$0.09 10-Q · filed 2017-08-09 | $0.05 10-Q · filed 2018-08-07 | -$0.06 10-Q · filed 2017-08-09 | |||
| 2016-12-31 | -$0.50 10-K · filed 2019-03-01 | -$0.72 10-K · filed 2017-03-01 | |||||
| 2016-06-30 | -$0.47 10-Q · filed 2017-08-09 | -$0.99 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | -$0.52 10-Q · filed 2016-05-05 | ||||||
| 2015-12-31 | -$0.74 10-K · filed 2017-03-01 | ||||||
| 2015-09-30 | -$0.30 10-Q · filed 2015-11-09 | -$0.14 10-Q · filed 2015-11-09 | |||||
| 2015-03-31 | -$0.14 10-Q · filed 2016-05-05 | $0.12 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.10 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.21 derived: net income ÷ weighted average shares · filed 2017-03-01 | |||
| 2014-12-31 | $0.26 derived: net income ÷ weighted average shares · filed 2017-03-01 | $0.04 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.07 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.33 10-K · filed 2017-03-01 | |||
| 2014-09-30 | -$0.23 10-Q · filed 2015-11-09 | -$0.33 derived: net income ÷ weighted average shares · filed 2015-11-09 | -$0.60 10-Q · filed 2015-11-09 | -$0.80 derived: net income ÷ weighted average shares · filed 2016-02-26 | |||
| 2014-06-30 | -$0.10 10-Q · filed 2014-08-04 | -$0.37 10-Q · filed 2014-08-04 | -$0.58 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$0.79 derived: net income ÷ weighted average shares · filed 2016-02-26 | |||
| 2014-03-31 | -$0.27 10-Q · filed 2015-05-05 | -$0.48 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$0.69 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$0.79 derived: net income ÷ weighted average shares · filed 2016-02-26 | |||
| 2013-12-31 | -$0.21 10-K · filed 2015-03-02 | -$0.42 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$0.52 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$0.55 10-K · filed 2016-02-26 | |||
| 2013-09-30 | -$0.21 10-K · filed 2015-03-02 | -$0.31 derived: net income ÷ weighted average shares · filed 2015-03-02 | -$0.33 10-Q · filed 2014-11-07 | ||||
| 2013-06-30 | -$0.09 10-K · filed 2015-03-02 | -$0.11 10-Q · filed 2014-08-04 | |||||
| 2013-03-31 | -$0.02 10-K · filed 2015-03-02 | ||||||
| 2012-12-31 | -$0.03 10-K · filed 2014-03-03 | -$0.65 10-K · filed 2015-03-02 | |||||
| 2012-09-30 | -$0.37 10-K · filed 2014-03-03 | -$0.63 10-Q · filed 2013-11-05 | |||||
| 2012-06-30 | -$0.01 10-K · filed 2014-03-03 | -$0.25 10-Q · filed 2013-08-06 | |||||
| 2012-03-31 | -$0.24 10-K · filed 2014-03-03 | ||||||
| 2011-12-31 | -$0.85 10-K · filed 2014-03-03 | ||||||
| 2011-09-30 | -$0.27 10-Q · filed 2012-11-06 | -$0.65 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | -$0.18 10-Q · filed 2012-08-06 | -$0.38 10-Q · filed 2012-08-06 | |||||
| 2011-03-31 | -$0.20 10-Q · filed 2012-05-09 | ||||||
| 2010-12-31 | -$0.62 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |